Please login to the form below

Not currently logged in
Email:
Password:

Open Health creates new role

Gavin Jones joins the agency as its director of rare disease

Gavin JonesIn order to strengthen their experience and expertise, healthcare communications and market access group Open Health has appointed Gavin Jones into its newly formed role of director of rare disease.

Jones will work in close partnership with all of the Open Health agencies, driving their existing and future partnerships with customers working in rare diseases.

He said: “Having the opportunity to fully utilise my expertise and knowledge in supporting our customers provide patients hope for the future is a fantastic opportunity [and] I’m honoured to be representing Open Health in this important investment.”

Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services.

Commenting on his appointments, Sandy Roydon, chief executive officer of Open Health, said: “We are delighted that Gavin has joined us to further strengthen our partnerships with customers in rare disease.

“Creating a unique role within our field of expertise will enable us to offer a market leading position in supporting our customers work towards greater access and uptake of their innovative and much needed treatments.”

9th March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics